NL-OMON55269招募中不适用
Prediction of Flucloxacillin Absorption and %time/MIC using the Flucloxacillin absorption test - PFAF
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •>=18 years
- •Admitted to the hospital, during inclusion
- •S aureus infection with continuous infusion of flucloxacillin
- •Clinically eligible to be switched to oral flucloxacillin
排除标准
- •ICU admittance
研究者
相似试验
进行中（未招募）
1 期
Flucloxacillin absorption test validation and optimalisation.S Aureus bacteraemia (indirectly)EUCTR2019-003933-40-NLHaaglanden Medisch Centrum20
已完成
不适用
Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU PatientsBacterial InfectionsNCT02993575Radboud University Medical Center30
招募中
不适用
Defining the optimal dose for continuous flucloxacillin infusion using pharmacokinetic modelling ;The FLUCON-studyinfectional disease10004018NL-OMON43049Deventer Ziekenhuis30
终止
1 期
Pharmacokinetic Issues of Moxifloxacin Plus RifapentineMycobacterium TuberculosisNCT00460759Johns Hopkins University15
进行中（未招募）
1 期
Pharmacokinetic evaluation of moxifloxacin administered intravenously and orally in healthy volunteers who have had a gastric bypass.Healthy volunteers who have had a gastric bypass at least 6 months agoEUCTR2010-018628-14-BEniversity Ghent